Medication Safety, Medicine
20 results
Applied filters
Using potassium permanganate for skin conditions or wound care
4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.
Supporting safe use of adrenal crisis emergency management kits
28 November 2024Treatment of adrenal crisis is time critical and relies on timely use of injectable hydrocortisone to prevent harm.
Managing the risk of confusion between injectable penicillin salts
16 October 2024Minimising the risk of confusion between injectable benzylpenicillin salt formulations may prevent harms.
Managing risks associated with oxytocin infusions during labour
23 September 2024Safety strategies can minimise the risk of harms related to oxytocin infusion overdose and delayed therapy.
Managing the risks associated with patients prescribed clozapine
28 June 2024Healthcare professionals in non-specialist services managing patients prescribed clozapine should implement safe practice principles to prevent potential harms.
Clinical considerations for patients prescribed clozapine
28 June 2024Healthcare professionals in all settings who interact with patients prescribed clozapine should be aware of clinical considerations related to its use.
Managing risks of betamethasone soluble tablets used as mouthwash
13 May 2024Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm.
Using intravenous paracetamol preparations safely in paediatrics
1 May 2024Safety risks and mitigation strategies are described to reduce the risk of errors with intravenous paracetamol in neonates, infants, and children.
Safety considerations when using Vitamin D
22 March 2024Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm
Managing the risks of using liquid oral phenobarbital
2 November 2023Minimising the risk of confusion between phenobarbital liquid formulations and awareness of alcohol content may prevent harms.